Literature DB >> 26770409

Up-regulation of microRNA-664 inhibits cell growth and increases cisplatin sensitivity in cervical cancer.

Yao Yang1, Hong Liu1, Xi Wang1, Long Chen1.   

Abstract

BACKGROUND: Cervical cancer is one of the leading causes of cancer-related death in woman worldwide. In the present study, we investigated the role of microRNA 664 (miR-664) in regulating cancer migration and chemotherapy sensitivity in cervical cancer.
METHODS: Quantitative real-time PCR (qPCR) was used to assess the mRNA levels of miR-664 in both cervical cancer cell lines and cancer tissues from human patients. Lentiviral vector containing miR-664 mimics (lv-miR-664) was used to upregulate endogenous miR-664 in cervical cancer HeLa cells. The effects of miR-664 up-regulation on cervical cancer cell migration and cisplatin sensitivity were assessed by MTT and Cisplatin assays. Furthermore, the effect of miR-664 up-regulation on E-Cadherin expression was examined by western blot. E-Cadherin was then silenced by siRNA to examine its effect on miR-664 regulation on cervical cancer cell.
RESULTS: MiR-664 was downregulated in both cervical cancer cell lines and cancer tissues in patients. In HeLa cells, lentivirus mediated miR-664 up-regulation reduced cancer cell migration and increased chemosensitivity to cisplatin. Western blot showed E-Cadherin was upregulated upon miR-664 overexpression in HeLa cells. Genetic silencing of E-Cadherin by siRNA reversed the inhibitory effect of miR-664 up-regulation on cervical cancer cell migration.
CONCLUSION: Our study demonstrated that miR-664 played an important role in regulating cervical cancer, possibly modulated by E-Cadherin.

Entities:  

Keywords:  E-cadherin; cervical cancer; miR-664

Year:  2015        PMID: 26770409      PMCID: PMC4694309     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  18 in total

1.  Changing roles of cadherins and catenins during progression of squamous intraepithelial lesions in the uterine cervix.

Authors:  C J de Boer; E van Dorst; H van Krieken; C M Jansen-van Rhijn; S O Warnaar; G J Fleuren; S V Litvinov
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

Review 2.  MicroRNAs and their role in gynecological tumors.

Authors:  Anna Torres; Kamil Torres; Ryszard Maciejewski; William H Harvey
Journal:  Med Res Rev       Date:  2010-03-31       Impact factor: 12.944

Review 3.  Cervical adenocarcinoma: moving towards better prevention.

Authors:  Muhieddine Seoud; Wiebren A A Tjalma; Veerle Ronsse
Journal:  Vaccine       Date:  2011-10-06       Impact factor: 3.641

4.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

5.  The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.

Authors:  Sun-Mi Park; Arti B Gaur; Ernst Lengyel; Marcus E Peter
Journal:  Genes Dev       Date:  2008-04-01       Impact factor: 11.361

Review 6.  Inactivation of the E-cadherin-mediated cell adhesion system in human cancers.

Authors:  S Hirohashi
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

7.  The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.

Authors:  Manav Korpal; Esther S Lee; Guohong Hu; Yibin Kang
Journal:  J Biol Chem       Date:  2008-04-14       Impact factor: 5.157

8.  Cervical Cancer: Development of Targeted Therapies Beyond Molecular Pathogenesis.

Authors:  Jayne Knoff; Benjamin Yang; Chien-Fu Hung; T-C Wu
Journal:  Curr Obstet Gynecol Rep       Date:  2014-03-01

Review 9.  MicroRNAs in cervical cancer: evidences for a miRNA profile deregulated by HPV and its impact on radio-resistance.

Authors:  Abraham Pedroza-Torres; Eduardo López-Urrutia; Verónica García-Castillo; Nadia Jacobo-Herrera; Luis A Herrera; Oscar Peralta-Zaragoza; César López-Camarillo; David Cantú De Leon; Jorge Fernández-Retana; Jorge F Cerna-Cortés; Carlos Pérez-Plasencia
Journal:  Molecules       Date:  2014-05-16       Impact factor: 4.411

Review 10.  Multistep model of cervical cancer: participation of miRNAs and coding genes.

Authors:  Angelica Judith Granados López; Jesús Adrián López
Journal:  Int J Mol Sci       Date:  2014-09-04       Impact factor: 5.923

View more
  12 in total

1.  MicroRNA-664-5p promotes myoblast proliferation and inhibits myoblast differentiation by targeting serum response factor and Wnt1.

Authors:  Rui Cai; Naren Qimuge; Meilin Ma; Yingqian Wang; Guorong Tang; Que Zhang; Yunmei Sun; Xiaochang Chen; Taiyong Yu; Wuzi Dong; Gongshe Yang; Weijun Pang
Journal:  J Biol Chem       Date:  2018-10-15       Impact factor: 5.157

Review 2.  Gene Therapy for Malignant and Benign Gynaecological Disorders: A Systematic Review of an Emerging Success Story.

Authors:  Ekati Drakopoulou; Nicholas P Anagnou; Kalliopi I Pappa
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

3.  Genome-wide miRNA response to anacardic acid in breast cancer cells.

Authors:  David J Schultz; Penn Muluhngwi; Negin Alizadeh-Rad; Madelyn A Green; Eric C Rouchka; Sabine J Waigel; Carolyn M Klinge
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

Review 4.  Targeted Gene Delivery Therapies for Cervical Cancer.

Authors:  Ángela Áyen; Yaiza Jiménez Martínez; Houria Boulaiz
Journal:  Cancers (Basel)       Date:  2020-05-21       Impact factor: 6.639

5.  miR-664a-3p functions as an oncogene by targeting Hippo pathway in the development of gastric cancer.

Authors:  Lu Wang; Bowen Li; Lu Zhang; Qing Li; Zhongyuan He; Xuan Zhang; Xiaoxu Huang; Zhipeng Xu; Yiwen Xia; Qiang Zhang; Qiang Li; Jianghao Xu; Guangli Sun; Zekuan Xu
Journal:  Cell Prolif       Date:  2019-03-18       Impact factor: 6.831

6.  Overexpression of miR-664 is associated with poor overall survival and accelerates cell proliferation, migration and invasion in hepatocellular carcinoma.

Authors:  Xianming Wang; Zhengtong Zhou; Tao Zhang; Minghai Wang; Rongwei Xu; Shiyong Qin; Shuguang Zhang
Journal:  Onco Targets Ther       Date:  2019-03-28       Impact factor: 4.147

7.  Identification and performance evaluation of housekeeping genes for microRNA expression normalization by reverse transcription-quantitative PCR using liquid-based cervical cytology samples.

Authors:  Rhafaela Lima Causin; Danielle Pessôa-Pereira; Karen Cristina Borba Souza; Adriane Feijó Evangelista; Rui Manuel Vieira Reis; José Humberto Tavares Guerreiro Fregnani; Márcia Maria Chiquitelli Marques
Journal:  Oncol Lett       Date:  2019-09-06       Impact factor: 2.967

8.  MicroRNA-664 suppresses the growth of cervical cancer cells via targeting c-Kit.

Authors:  Mingfen Lv; Rongying Ou; Qianwen Zhang; Fan Lin; Xiangyun Li; Keyu Wang; Yunsheng Xu
Journal:  Drug Des Devel Ther       Date:  2019-07-17       Impact factor: 4.162

9.  Overexpression Of hsa-miR-664a-3p Is Associated With Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease Via Targeting FHL1.

Authors:  Shan Zhong; Chengshui Chen; Naijia Liu; Li Yang; Zhangli Hu; Pengfei Duan; Diquan Shuai; Qingying Zhang; Yun Wang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-10-09

10.  The expression of microRNA 574-3p as a predictor of postoperative outcome in patients with esophageal squamous cell carcinoma.

Authors:  Tomoyuki Okumura; Hirohumi Kojima; Takeshi Miwa; Shinichi Sekine; Isaya Hashimoto; Shozo Hojo; Takuya Nagata; Yutaka Shimada
Journal:  World J Surg Oncol       Date:  2016-08-26       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.